The prevalence of microhematuria among healthy patients ranges from 2.4% to 31.1%.1 Although 13.1% of gross hematuria episodes are associated with malignancy, only 0.3% to 6.3% (depending on population) of microhematuria episodes are associated with malignancy.2,3
Judge C, Cifu AS, Faris S. Management of Patients With Microhematuria. JAMA. 2021;326(6):563–564. doi:10.1001/jama.2021.4770
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.